Comparing Two Peanut Desensitization Protocols in Preschool Children: A Real-World Clinical Practice

Adnan Al Ali1, Karen Sigman1, Roy Khalaf2

  • 1Division of Allergy and Clinical Immunology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Québec, Canada.

Insights

Peanut desensitization using peanut puffs significantly reduced allergic reaction severity in children compared to crushed peanuts. Younger children benefited most, while older children may require tailored approaches.

Area of Science:

  • Allergy and Immunology
  • Pediatric Medicine
  • Clinical Trial Research

Background:

  • Peanut allergy is a prevalent childhood food allergy with significant health implications.
  • Oral immunotherapy (OIT) is a treatment option for peanut allergy.
  • This study compares the effectiveness and safety of OIT using peanut puffs versus crushed peanuts.

Purpose of the Study:

  • To evaluate the efficacy of peanut puffs versus crushed peanuts in oral immunotherapy for peanut allergy.
  • To assess the safety and reaction severity associated with different OIT formulations.
  • To identify factors influencing reaction severity during peanut OIT.

Main Methods:

  • 191 children with diagnosed peanut allergy were enrolled in a comparative study.
  • Participants received OIT with either crushed peanuts or peanut puffs.
  • Reaction severity was analyzed using regression models, adjusting for confounders.

Main Results:

  • Peanut puff OIT reduced reaction severity by a factor of 3.94 compared to crushed peanuts.
  • Older age was associated with a 1.20-fold increased odds of reacting to a particular severity level.
  • The study included a median age of 1.95 years, with 75.1% having eczema and 12.7% asthma.

Conclusions:

  • Peanut puffs show promise in mitigating allergic reaction severity during OIT, particularly in younger children.
  • Age-specific desensitization protocols may be necessary due to increased risk in older children.
  • Modified OIT strategies can improve safety and tolerability in pediatric peanut allergy management.
Abstract